Pharma Journalist 9007 posts 0 comments

Star Therapeutics has announced the closing of an oversubscribed $125 million Series D financing round to accelerate the development of its pipeline of antibody-based therapies,…
Read More...

Klotho Neurosciences, Inc. has announced it has signed a Letter of Intent (LOI) to acquire select assets from Turn Biotechnologies, Inc., a pioneer in cellular reprogramming and induced…
Read More...

Pfizer has announced a historic agreement with the Trump Administration aimed at significantly reducing prescription drug prices for American patients while reinforcing the U.S.'s…
Read More...

AbbVie has broken ground on a $70 million expansion of its AbbVie Bioresearch Center (ABC) in Worcester, Massachusetts, a key hub for the company’s biologics research, development, and…
Read More...

BioLineRx Ltd. and Norwegian biotech Hemispherian AS have established a joint venture to develop GLIX1, a first-in-class oral small molecule designed to target DNA damage response in…
Read More...

Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Rhapsido (remibrutinib), an oral treatment for adult patients with chronic spontaneous urticaria (CSU)…
Read More...

AbbVie has begun construction on a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago, Illinois, marking a major step in expanding its U.S. manufacturing…
Read More...

Labcorp, a global leader in laboratory services, announced a collaboration with Roche to implement the FDA-cleared VENTANA DP 600 and DP 200 digital slide scanners. This investment will…
Read More...

BenchSci, a global leader in AI for preclinical research and drug discovery, announced a strategic partnership with Thermo Fisher Scientific, the world leader in scientific services and…
Read More...

AstraZeneca and Daiichi Sankyo announced positive interim results from the DESTINY-Breast05 Phase III trial, reinforcing Enhertu’s (trastuzumab deruxtecan) potential as a foundational…
Read More...